These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11232730)

  • 1. Sustained remission of chronic hepatitis C after a change to human leukocyte interferon-alpha in a difficult-to-treat patient with breakthrough phenomenon associated with antibodies against recombinant interferon-alpha.
    Berg T; Hopf U; Schuff-Werner P
    Am J Gastroenterol; 2001 Feb; 96(2):612-4. PubMed ID: 11232730
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C.
    van der Eijk AA; Vrolijk JM; Haagmans BL
    N Engl J Med; 2006 Mar; 354(12):1323-4. PubMed ID: 16554542
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutralizing antibodies to interferon alpha in a chronic hepatitis C patient non-responder to pegylated interferon.
    Santantonio T; Milella M; Antonelli G; Scagnolari C
    J Hepatol; 2006 Nov; 45(5):759-61. PubMed ID: 16979777
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection.
    Bálint E; Bakay M; Onody K; Farkas F; Horváth G; Tolvaj G; Dávid K; Horányi M; Béládi I
    Acta Microbiol Immunol Hung; 2004; 51(3):359-69. PubMed ID: 15571075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C.
    Hoffmann RM; Berg T; Teuber G; Prümmer O; Leifeld L; Jung MC; Spengler U; Zeuzem S; Hopf U; Pape GR
    Z Gastroenterol; 1999 Aug; 37(8):715-23. PubMed ID: 10494606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Breakthrough" during interferon therapy for chronic hepatitis C. Overview on the diagnosis, possible aetiology and recommendations for management.
    Colloredo G; Roffi L; Bellati G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):333-7. PubMed ID: 9759607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C.
    Mizukoshi E; Kaneko S; Kaji K; Terasaki S; Matsushita E; Muraguchi M; Ohmoto Y; Kobayashi K
    Hepatology; 1999 Nov; 30(5):1325-31. PubMed ID: 10534358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.
    Nouri K; Busso M; Machler BC
    Cutis; 1997 Dec; 60(6):289-90. PubMed ID: 9426968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant alpha-2b-interferon in combination with antioxidants in the form of rectal suppositories (viferon) in children with chronic hepatitides B and C.
    Uchaikin V; Cherednichenko T; Malinovskaya V; Orlova T; Kovalev O; Kharlamova F; Chaplygina G; Konev V; Voronina F; Delenian N
    Acta Virol; 2000 Apr; 44(2):79-83. PubMed ID: 10989698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suicide in a patient with chronic viral hepatitis C treated with interferon-alpha: favoring role of alcohol?].
    Bacq Y; Tantaoui Elaraki A; Metman EH
    Gastroenterol Clin Biol; 1997; 21(10):797-8. PubMed ID: 9587525
    [No Abstract]   [Full Text] [Related]  

  • 11. LKM1 antibody and interferon therapy in children with chronic hepatitis C.
    Iorio R; Giannattasio A; Vespere G; Vegnente A
    J Hepatol; 2001 Nov; 35(5):685-7. PubMed ID: 11690721
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disappearance of serum autoantibodies during treatment with interferon alpha in a patient with chronic hepatitis C].
    Khemissa F; Bauget P; Michel H; Larrey D
    Gastroenterol Clin Biol; 1997; 21(12):998-9. PubMed ID: 9587568
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon treatment for thrombocytopenia associated with chronic HCV infection.
    Uygun A; Kadayifci A; Ercin N; Bagci S; Dagalp K
    Int J Clin Pract; 2000 Dec; 54(10):683-4. PubMed ID: 11221286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of immune response to etiotropic and pathogenetic therapy in children with chronic hepatitis C].
    Vasil'eva DK; Goriacheva LG; Monakhova NE
    Eksp Klin Farmakol; 2011; 74(12):33-5. PubMed ID: 22379880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced in vitro immunoglobulin secretion from peripheral blood mononuclear cells in responders to high-dose interferon-alpha 2b treatment for chronic hepatitis C.
    Atsukawa K; Saito H; Ebinuma H; Morizane T; Takahashi M; Ohishi T; Kumagai N; Tsuchimoto K; Ishii H
    Hepatogastroenterology; 2000; 47(36):1685-90. PubMed ID: 11149032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.
    Milella M; Antonelli G; Santantonio T; Giannelli G; Currenti M; Monno L; Turriziani O; Pastore G; Dianzani F
    Hepatogastroenterology; 1995 Jul; 42(3):201-4. PubMed ID: 7590565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.
    Perasso A; Testino G; Ansaldi F; Venturino V; Icardi GC
    Hepatology; 1999 Jan; 29(1):297-8. PubMed ID: 9935339
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pegylated interferon: new progress in treatment for chronic hepatitis C].
    Boyer N; Marcellin P
    Gastroenterol Clin Biol; 2000; 24(8-9):767-9. PubMed ID: 11011255
    [No Abstract]   [Full Text] [Related]  

  • 20. Complete remission of cryoglobulinemic glomerulonephritis (HCV-positive) after high dose interferon therapy.
    Laganović M; Jelaković B; Kuzmanić D; Sćukanec-Spoljar M; Roncević T; Cuzić S; Ostojić R
    Wien Klin Wochenschr; 2000 Jul; 112(13):596-600. PubMed ID: 10944819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.